ADALIMUMAB

Adalimumab 20 mg/0.2 mL injection, 0.2 mL syringe

ADALIMUMAB (15571M)

Adalimumab 20 mg/0.2 mL injection, 0.2 mL syringe
15571M
Body System:
Manner of administration:Injection
Public
S100 HSD Public
Authority Required

Restriction

Indication: Severe active juvenile idiopathic arthritis
Treatment phase: Transitioning from non-PBS to PBS-subsidised treatment - Grandfather arrangements
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 2 # of repeats: 5 DPMQ: $545.68 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Amgevita